NASDAQ:VERA | Profit Breakdown | Vera Therapeutics, Inc.

Complete filed revenue-to-profit bridge showing gross profit, operating income, pre-tax income and net income.

Available history
2020-03-31 to 2026-06-30
Data captured

Historical Profit Breakdown

DateRevenueGross profitOperating incomePre-tax incomeNet income
2026-06-30-$112.49M-$109.47M
2026-03-31-$125.13M-$121.03M
2025-12-31-$94.21M-$91.1M
2025-09-30-$83.93M-$80.29M
2025-06-30-$80.14M-$76.53M
2025-03-31-$57.19M-$51.69M
2024-12-31-$48.91M-$43.43M
2024-09-30-$49.8M-$46.63M
2024-06-30-$37.34M-$33.71M
2024-03-31-$31.11M-$28.38M
2023-12-31-$27.03M-$25.66M
2023-09-30-$21.76M-$20.1M
2023-06-30-$21.97M-$20.16M
2023-03-31-$31.26M-$30.07M
2022-12-31-$33.58M-$32.44M
2022-09-30-$25.24M-$24.68M
2022-06-30-$15.06M-$14.85M
2022-03-31-$17.02M-$17.09M
2021-12-31-$16.59M-$16.85M
2021-09-30-$7.25M-$7.61M
2021-06-30-$5.85M-$3.44M
2021-03-31-$4.72M-$4.71M
2020-12-31-$42.56M-$42.88M
2020-09-30-$4.04M-$4.46M
2020-06-30-$3.17M-$3.6M
2020-03-31-$2.47M-$2.47M

Annual Profit Breakdown

DateRevenueGross profitOperating incomePre-tax incomeNet income
2025-12-31-$315.47M-$299.61M-$299.62M
2024-12-31-$167.17M-$152.15M-$152.15M
2023-12-31-$102.01M-$95.99M-$95.99M
2022-12-31-$90.9M-$89.06M-$89.06M
2021-12-31-$34.4M-$32.61M-$32.61M
2020-12-31-$52.24M-$53.41M-$53.41M

Research interface only. Not investment advice. Prices are a checked-in snapshot, not live quotes.